معرفی
Tilla S. Worgall, MD, PhD, is a Professor of Pathology and Cell Biology at Columbia University Medical Center (CUMC). She serves as Assistant Director of Special Chemistry and holds hospital affiliations with NewYork-Presbyterian/Columbia University Irving Medical Center. Her research focuses on metabolic disorders, lipid biology, and respiratory diseases, particularly investigating sphingolipid metabolism’s role in conditions like cystic fibrosis and atherosclerosis.
Education includes a PhD from Heidelberg Medical School (Germany) and residencies at J Wolfgang Goethe University (Frankfurt) and NewYork-Presbyterian Hospital/Columbia University Medical Center. She completed clinical pathology fellowships at Columbia and is board-certified in Clinical Pathology.
Her publications span sphingolipid signaling in airway hyperreactivity, lipid dysregulation in atherosclerosis, and nucleic acid-based biosensor technologies. Research trends emphasize translational applications of lipid metabolism insights to respiratory and cardiovascular diseases. No formal student advising record or grants are listed in the provided text.
